about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
10.53
0.21
(2.03%)
1.3M
XNAS Volume
XNAS 04 Dec, 2025 4:12 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..